2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$217.51+$1.39 (+0.64%)
Price as of Jul 06, 2026 4:10 AM EDT- $31.9BMarket Cap
- 62.66%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$217.51+$1.39 (+0.64%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $216.12 | ||
Change | +$6.38 (+3.04%) | ||
Open | $212.74 | ||
High | $219.01 | ||
Low | $210.75 | ||
Previous Close | $209.74 | ||
Volume | 1,155,166 | ||
30-Day Average Volume | 1,172,478 | ||
1-Week Change | 7.01% | ||
1-Month Change | 14.45% | ||
1-Year Change | 62.66% | ||
3-Year Change | -24.13% | ||
5-Year Change | -38.02% | ||
Fundamentals | |||
Shares Outstanding | 147.6M | ||
Total Assets | $29.5B | ||
Market Cap | $31.9B | ||
Enterprise Value | $34.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.8B | ||
Net Income | $319.5M | ||
Free Cash Flow | $594.3M | ||
EBIT | $445.3M | ||
EBITDA | $649.7M | ||
Net Working Capital | $6.2B | ||
EPS | $2.15 | ||
Enterprise Value/EBITDA | 54 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 2 | ||
P/E | 101 | ||
PEG | 0 | ||
Price/Free Cash Flow | 54 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue